Blum&Grob advises the Wyss Zurich project LifeMatrix in establishing its spin-off entity
The multidisciplinary LifeMatrix team of Wyss Zurich is developing a unique innovative tissue engineering technology to grow replacement tissue in the laboratory, which will be compatible with every patient, regenerate and grow with the recipient. This technology is particularly promising for the treatment of children born with a heart defect. Blum&Grob is advising the LifeMatrix team in legal matters and has particularly contributed to the incorporation of the spin-off entity LIFEMATRIX TECHNOLOGIES Ltd with registered offices in Zurich.
NFTs in Metaverse: Do Trademark Owners need to register their Trademarks for Virtual Goods and Services?
“Nike Sold an NFT Sneaker for USD 134’000”: This York Times headline of May 26, 2022 and similar headlines regarding virtual goods in Metaverses or NFT Trade Platforms have made us realize that NFTs are not only for digital art but also a huge market for brand products.
New Proposal for Swiss Corporate Tax Reform
The Steering Committee representing the cantons and Swiss Federation issued its recommendation regarding the implementation of a modified corporate tax reform to the Swiss Federal Council on June 1, 2017. The corporate tax reform has been renamed the Tax Proposal (“T.P. 17”) and is, in general, based on the Corporate Tax Reform III (“C.T.R. III”), which was rejected on February 12, 2017, by Swiss voters.